TNNT2 and chronic kidney disease: This may restrict the use of cTnT or cTnI assays for diagnosing acute myocardial events in patients with reduced glomerular filtration rate (GFR), but it may also highlight the predictive value of troponins for CV complications in CKD patients [14,15].